• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION WATCHMAN TRUSEAL ACCESS SYSTEM; SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL Back to Search Results
Model Number M635TU70020
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Cardiac Tamponade (2226); Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 08/06/2021
Event Type  Injury  
Event Description
It was reported that a perforation, pericardial effusion and cardiac tamponade occurred.A left atrial appendage (laa) closure procedure was being performed.A double curve watchman truseal access system (was) was positioned and a 24mm watchman flx laa closure device & delivery system (wds) were used.There was trace amount of fluid noted in the transverse sinus but otherwise no pericardial effusion was noted before the procedure.The 24mm watchman flx device was implanted with just one deployment, and no recaptures or partial recaptures were performed.Sweeps were performed before device deployment and after release criteria was checked.The effusion was noted after release criteria was discussed.After the device was implanted the patient's blood pressure dropped, heart rate increased and there was some right atrium collapse and a large pericardial effusion was noted posterior to the heart near the left ventricle and left atrium.With time the perforation was noted on transesophageal echo (tee) imaging to be in the laa.Initially a pericardiocentesis was performed to manage the pericardial effusion.Once it became clear that the perforation was not going to seal or clot off the patient was taken to surgery.Surgery was performed and three sutures were used to repair the perforation.The watchman flx device remains implanted.The patient did well and was expected to be discharged a few days post surgery.It remains unclear when exactly the perforation occurred but most likely it seemed to have happened during the time of the was entry into the left atrium/laa and pigtail catheter entry into the left atrium/laa.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
WATCHMAN TRUSEAL ACCESS SYSTEM
Type of Device
SYSTEM, APPENDAGE CLOSURE, LEFT ATRIAL
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12385761
MDR Text Key268730599
Report Number2134265-2021-10944
Device Sequence Number1
Product Code DQY
UDI-Device Identifier08714729965718
UDI-Public08714729965718
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 08/30/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberM635TU70020
Device Catalogue NumberM635TU70020
Device Lot Number0027360995
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/06/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured05/21/2021
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
-
-